ADVANCES IN THE DIAGNOSIS AND TREATMENT OF THE RHEUMATIC DISEASES
Held: June 6th & 7th, 2008
Course Description
Now in its fourth year, this two-day symposium has been planned for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This activity is intended for rheumatologists, internists, gerontologists, orthopedic surgeons and other allied health professionals.
Objectives
Following this activity, the participant should be able to:
- Discuss recent advances in the use of biologic agents in the treatment of rheumatoid and psoriatic arthritis.
- Appreciate the unique challenges associated with the treatment of the geriatric patient with rheumatic disease.
- Discuss new and emerging issues in the therapy and treatment of systemic lupus erythematosus.
- Understand major risk factors for the development and progression of osteoarthritis.
- Be able to recognize the major neurologic and dermatologic manifestations of the rheumatic diseases.
- Learn how to manage patients with Juvenile Chronic Polyarthritis.
- Understand the current approach to therapy for Fibromyalgia.
- Discuss the rheumatic manifestations of Lyme disease.
- Appreciate new advances in diagnosis and treatment for the inflammatory myopathies and systemic vasculitides.
Policy on Speaker and Provider Disclosure
It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Detailed disclosure will be made in the activity handout materials.
Registration
Closed - Event Passed